510(k) Report

510(k) · Cleared

Cleared

Dri Methadone Metabolite (100/300) Assay, Calibrators and Controls

K081378510(k) TraditionalCleared Jan 14, 2009243-day reviewClass II21 CFR 862.3620

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Thermo Fisher Scientific · DJR Enzyme Immunoassay, Methadone

Cleared on Jan 14, 2009 as substantially equivalent to K980746 (Boehringer Mannheim Corp., 1998) and 2 other predicates after a 243-day review. Its family tree reaches back 2 generations to 1993. 1 later device descends from it.

Decided
Jan 14, 2009
Review
243 days
Class
Class II
Product code
DJR
Recalls
None
Predicates
3

Its longest line of descent runs back 2 generations to K931780 (1993). 5 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2004: 1 other ancestor1998: 1 other ancestor1995: 1 other ancestor2010: 1 descendant clearedK931780 · Methadone Metabolite Eia Assay · Diagnostic Reagents, Inc. · 1993K980746 · Cedia Dau Eddp Assay · Boehringer Mannheim Corp. · 19981990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors2 generations back: 1 other ancestor 1 generation forward: 1 descendant K980746 · Cedia Dau Eddp Assay · Boehringer Mannheim Corp. · 1998K931780 · Methadone Metabolite Eia Assay · Diagnostic Reagents, Inc. · 19930
  1. Root · 2 generations backK931780 Methadone Metabolite Eia AssayDiagnostic Reagents, Inc. · 1993
  2. 1 generation backK980746 Cedia Dau Eddp AssayBoehringer Mannheim Corp. · 1998
  3. This deviceK081378 Dri Methadone Metabolite (100/300) Assay, Calibrators and ControlsThermo Fisher Scientific · 2009
  4. Descendant · cites it directly · 0 of its ownK092048 One Step Eddp (Methadone Metabolite) Test StripBiosite Incorporated · 2010

Most influential descendants

Showing 1 of 1 · See all
  • K092048One Step Eddp (Methadone Metabolite) Test StripBiosite Incorporated · 2010 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K931780Methadone Metabolite Eia AssayDiagnostic Reagents, Inc.1993—
−1K980746Cedia Dau Eddp AssayBoehringer Mannheim Corp.1998—
0 (this device)K081378Dri Methadone Metabolite (100/300) Assay, Calibrators and ControlsThermo Fisher Scientific2009—
+1K092048One Step Eddp (Methadone Metabolite) Test StripBiosite Incorporated2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510
199810
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
FIG. 1 — Lineage of K081378, 1993–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DJR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K980746Cedia Dau Eddp Assay
Summary page 2
…MARKETED DEVICE TO WHICH EQUIVALENCY IS CLAIMED The DRI Methadone Metabolite (100/300) Assay is substantially equivalent to the previously cleared CEDIA DAU EDDP Assay (K980746, Microgenics Corporation). The DRI Methadone Metabolite Calibrators are substantially equivalent to the previously cleared CEDIA…
Boehringer Mannheim Corp.1998—
*K980853Cedia Dau Multi-Drug Calibrators
Summary page 2
…ay (K980746, Microgenics Corporation). The DRI Methadone Metabolite Calibrators are substantially equivalent to the previously cleared CEDIA DAU Multi-Drug Calibrators (K980853, Microgenics Corporation). The DRI Methadone Metabolite Controls are substantially equivalent to the previously cleared MGC DAU…
Boehringer Mannheim Corp.1998—
*K040758MGC Dau Control Sets: Primary, Clinical and Select
Summary page 2
…Microgenics Corporation). The DRI Methadone Metabolite Controls are substantially equivalent to the previously cleared MGC DAU Control Sets: Primary, Clinical, Select (K040758, Microgenics Corporation). DESCRIPTION OF DEVICE The DRI Methadone Metabolite (100/300) Assay utilizes liquid ready-to-use reage…
Microgenics Corp.2004—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K092048One Step Eddp (Methadone Metabolite) Test StripBiosite Incorporated20100

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 3 companies; a new generation was cleared every 10.6 years on median.
  • None of the 5 ancestors has a recall.
  • Of its descendants, K092048 (Biosite Incorporated, 2010) has gone furthest, with 0 descendants of its own.

How does its category compare?

All DJR devices

DJR Enzyme Immunoassay, Methadone: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · DJR

1in 2019

2009: 12010: 32013: 12015: 32016: 12017: 12018: 12019: 1
2007high 3 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DJR

59in 2015

2010: 469 days median2015: 59 days median
2007high 469 (2010) · low 59 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DJR

1in 2010

2008: 22009: 12010: 1
2007high 2 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DJR

1in 2025

2010: 32011: 62012: 12014: 22015: 22016: 12025: 1
2007high 6 (2011) · low 0 (2007)2025

MAUDE reports naming product code DJR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—20
20091—10
2010346913
20110—06
20120—01
20131—00
20140—02
201535902
20161—01
20171—00
20181—00
20191—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—01
20260—0—

What is it indicated for?

The DRI Methadone Metabolite (1001300) Assay is intended for the qualitative and semi-quantitative determination of the presence of Methadone Metabolite (2-ethylidene-1,,5-dimethyl-3,3-diphenylpyrrolidine or EDDP) in human urine at cutoffs of 100 and 300 ng/mL. The DRI Methadone Metabolite Calibrators are intended for use in calibration of the DRI Methadone Metabolite (100/300) Assay. The DRI Methadone Metabolite Controls are intended for use in the DRI…

Read the full statement (164 words)

The DRI Methadone Metabolite (1001300) Assay is intended for the qualitative and semi-quantitative determination of the presence of Methadone Metabolite (2-ethylidene-1,,5-dimethyl-3,3-diphenylpyrrolidine or EDDP) in human urine at cutoffs of 100 and 300 ng/mL.

The DRI Methadone Metabolite Calibrators are intended for use in calibration of the DRI Methadone Metabolite (100/300) Assay.

The DRI Methadone Metabolite Controls are intended for use in the DRI Methadone Metabolite (100/300) Assay to detect and monitor systematic deviations from accuracy resulting from reagent or instrument defects.

The assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used to obtain a confirmed analytical result. Gas chromatography / Mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical and professional judgment should be applied to any drug of abuse test result, particularly when preliminary results are used. Tests for-methadone metabolite cannot distinguish between abused drugs and certain prescribed medications. Certain foods or medications may interfere with tests for methadone metabolite and cause false positive results.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K081378: Dri Methadone Metabolite (100/300) Assay, Calibrators and Controls.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K081378

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026